Contact

Root Meridian Home About Services Contact Thailand / legal & safety signal Ibogaine in Thailand An independent resource on ibogaine, law, and safety in Thailand. This page separates treatment marketing from the legal and health uncertainty people need to understand. 01 / baseline Start with the legal reality. Thailand’s rehabilitation and medical-tourism market can create a misleading impression of access. Ibogaine is not legally available as a medical treatment in Thailand. Definition A psychoactive alkaloid Ibogaine’s documented background describes a psychoactive alkaloid associated with the root bark of Tabernanthe iboga , a West African shrub. Legal status Not a licensed treatment For people considering travel, the essential point is that ibogaine is described as prohibited for individual use, possession, or import in Thailand, rather than offered through a recognized medical pathway. Risk signal Claims are not safeguards Marketing language about “therapy” or “wellness” does not resolve legal exposure or establish the cardiac screening, monitoring, and emergency capacity a high-risk substance may require. 02 / scanline briefing Why Thailand can be confusing for people researching ibogaine. Ibogaine sits at the intersection of strict narcotics law, addiction tourism, and shifting global psychedelic policy. Thailand is widely promoted for addiction rehabilitation, but that does not make ibogaine a legal treatment option there. Some directories and marketing pages may refer to private offerings in Bangkok or elsewhere. A page describing ibogaine in Thailand should be read as a prompt for careful verification, not proof that an offering is lawful, medically supervised, or appropriate. What the health risk means in practice Ibogaine can produce a prolonged dissociative or psychedelic state and is associated with significant cardiac concerns, including QT prolongation and arrhythmias. The Stanford discussion of ibogaine research and safety underscores why medical

Published contact details will appear here.